Johnson and Johnson Newswire (Page 5)

Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 36,813 in Johnson and Johnson

  1. UPDATE 1-J&J unit's former execs convicted of unapproved marketingRead the original story w/Photo

    Wednesday Jul 20 | Reuters

    Two former executives of Acclarent Inc, a medical device company bought by Johnson & Johnson in 2010, were convicted on Wednesday by a U.S. jury on charges of promoting a product for an unapproved use. Former Acclarent Chief Executive William Facteau and former Vice President of Sales Patrick Fabian were found guilty in federal court in Boston of 10 misdemeanor counts of violating the U.S. Food, Drug and Cosmetic Act, federal prosecutors said in a statement.

    Comment?

  2. Here's My Top Stock to Buy in JulyRead the original story w/Photo

    Wednesday Jul 20 | The Motley Fool

    The world will turn its attention to Brazil next month as it hosts the Olympics. Bargain-hunting investors may want to do the same.

    Comment?

  3. Jury Acquits Former Johnson & Johnson Unit Execs of Felony FraudRead the original story w/Photo

    Wednesday Jul 20 | Wall Street Journal

    A federal jury in Boston on Wednesday found two former senior officers at a Johnson & Johnson division guilty of illegally marketing a medical device, but acquitted them of more serious charges including fraud, according to prosecutors and defense lawyers. After a six-week trial, the jury convicted William Facteau, 47, of Atherton, Cal., and Patrick Fabian, 49, of Lake Elmo, Minn., of 10 misdemeanor counts of introducing adulterated and misbranded medical devices into interstate commerce.

    Comment?

  4. Birkenstock will pull its shoes from Amazon over counterfeit sellersRead the original story w/Photo

    Wednesday Jul 20 | Mashable

    Fed up with counterfeit products and unauthorized sellers, the iconic sandal retailer is planning to remove its merchandise from the e-commerce giant beginning January 1, 2017. Birkenstock USA CEO David Kahan announced the decision - with that all-caps warning - in a July 5 memo to retail partners, as reported by CNBC .

    Comment?

  5. Johnson & Johnson (JNJ) Stock Rating Reaffirmed by RBC Capital MarketsRead the original story w/Photo

    Wednesday Jul 20 | AmericanBankingNews.com

    's stock had its "outperform" rating restated by investment analysts at RBC Capital Markets in a research note issued on Wednesday. They currently have a $133.00 price target on the stock, up from their previous price target of $125.00.

    Comment?

  6. What Is Driving The S&P To New Highs?Read the original story w/Photo

    Wednesday Jul 20 | Seeking Alpha

    With the S&P 500 Index reaching all-time highs, a natural question to ask is not just "how is this happening?" but "who is responsible?" Through July 15 of this year, if we take a look at the top 10 performers in the S&P 500 with at least .5% weight in the index, we find that 10 generals have helped the market recover from the transient tribulation set off by Brexit. While the S&P is up 7% in 2016, all 10 of the stocks listed above have advanced more than 20% this year.

    Comment?

  7. Contact Lens Market 2016 Global Trends, Market Share, Industry Size,...Read the original story

    Wednesday Jul 20 | World News Report

    PUNE, INDIA, July 20, 2016 / EINPresswire.com / -- About the Contact Lens Market Contact lenses are a replacement for corrective glasses due to their better aesthetic and cosmetic appeal. They are thin lenses that are placed directly on the surface of the eye and are worn to correct vision or for other therapeutic purposes.

    Comment?

  8. 10 Best Dividend Stocks to Own Now for a Safe RetirementRead the original story w/Photo

    Wednesday Jul 20 | TheStreet.com

    With interest rates sitting near record lows, the stock market hitting all-time highs, and global growth remaining sluggish, many conservative investors seeking safe retirement income are anxious. Dividend stocks have been a popular place to hunt for retirement income because they offer yields higher than Treasuries and provide the potential for income growth and capital appreciation.

    Comment?

  9. Google's Demographic Squeeze PlayRead the original story w/Photo

    Wednesday Jul 20 | MediaPost

    One thing we love about Google is its penchant for coming up with marketing ploys that only it could execute or even acknowledge. Case in point: A recent Google claim that marketers are losing up to 70% of "potential mobile shoppers" by relying on conventional demographic suppositions.

    Comment?

  10. Johnson & Johnson's (JNJ) "Buy" Rating Reaffirmed at BMO Capital MarketsRead the original story w/Photo

    Wednesday Jul 20 | AmericanBankingNews.com

    's stock had its "buy" rating restated by equities researchers at BMO Capital Markets in a research note issued on Wednesday. They currently have a $132.00 price objective on the stock.

    Comment?

  11. Leerink Swann Reiterates Outperform Rating for Johnson & JohnsonRead the original story w/Photo

    Wednesday Jul 20 | AmericanBankingNews.com

    's stock had its "outperform" rating reiterated by stock analysts at Leerink Swann in a research note issued on Wednesday. They presently have a $140.00 target price on the stock, up from their previous target price of $125.00.

    Comment?

  12. Johnson & Johnson (JNJ) Announces Quarterly Dividend of $0.29Read the original story w/Photo

    Wednesday Jul 20 | AmericanBankingNews.com

    Johnson & Johnson announced a quarterly dividend on Wednesday, July 20th. Stockholders of record on Friday, August 5th will be paid a dividend of 0.29 per share on Friday, August 19th.

    Comment?

  13. VIDEO: Johnson & Johnson VP talks about #AIDS2016Read the original story w/Photo

    Wednesday Jul 20 | Iol.co.za

    Dr Paul Stoffels, Executive Vice President and Chief Scientific Officer for Johnson & Johnson, answers questions pertinent to the 2016 International Aids Conference.

    Comment?

  14. Global stocks resilient amid solid corporate earningsRead the original story w/Photo

    Wednesday Jul 20 | Star-Telegram.com

    Stock markets around the world were proving resilient on Wednesday in the face of a fairly gloomy economic outlook from the International Monetary Fund. How U.S. markets perform, however, could hinge on a raft of corporate earnings statements.

    Comment?

  15. 3 Compelling Reasons to Buy Johnson & Johnson Following EarningsRead the original story w/Photo

    Wednesday Jul 20 | TheStreet.com

    This health and drug giant is the best in its class. Here is why investors need to load up on J&J stock, which won't disappoint over the long run.

    Comment?

  16. SmarTrend Morning Call for July 20, 2016Read the original story w/Photo

    Wednesday Jul 20 | Minyanville

    This article is published in collaboration with Scutify , where you can find real-time markets and stock commentary from Robert Marcin, Cody Willard and others. Download the Scutify iOS App , the Scutify Android App or visit Scutify.com.

    Comment?

  17. Mass Beauty Care Industry US Analysis by Region, Major Vendors,...Read the original story

    Wednesday Jul 20 | World News Report

    PUNE, INDIA, July 20, 2016 / EINPresswire.com / -- Wiseguyreports.Com Adds " Mass Beauty Care Market - US Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2020" To Its Research Database. Analysts forecast the mass beauty care market in the US to grow at a CAGR of 2.59% during the period 2016-2020.

    Comment?

  18. 's Top UpgradesRead the original story w/Photo

    Wednesday Jul 20 | Benzinga

    KeyBanc upgraded Papa John's Int'l, Inc. from Sector Weight to Overweight. Papa John's shares rose 1.62 percent to $70.24 in pre-market trading.

    Comment?

  19. Dow inches to record high in mixed dayRead the original story w/Photo

    Wednesday Jul 20 | San Mateo Daily Journal

    Stocks ended mixed Tuesday as investors let up on the accelerator after a three-week rally sent indexes to all-time highs. The Dow Jones industrial average inched 25.96 points higher, or 0.1 percent, for its eighth consecutive gain to set another record at 18,559.01.

    Comment?

  20. Stralem & Co. Inc. Sells 16,100 Shares of Johnson & JohnsonRead the original story w/Photo

    Wednesday Jul 20 | Daily Political

    Stralem & Co. Inc. reduced its stake in Johnson & Johnson by 9.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission.

    Comment?